The topiramate component provides unique benefits beyond appetite suppression
Herbrich S, Baggerly K, Alatrash G, Davis RE, Andreeff M , Konopleva MY
References & Sources SURPASS-2 Trial (N Engl J Med) SURMOUNT-1 Trial (N Engl J Med) SELECT Trial Semaglutide CV Outcomes (N Engl J Med) SUMMIT Trial Tirzepatide HFpEF (N Engl J Med) Eli Lilly SURPASS-2 Results (Press Release) Eli Lilly SURMOUNT-1 Results (Press Release) ADA SURPASS Data Presentation SUMMIT Trial ACC Summary SELECT Trial ACC Summary Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice
September 2024 FDA warning related to weight loss marketing claims
Our specialists customize every treatment to align with your body and objectives for maximum effectiveness
Jon writes evidence-led guidance on medicines, supplements and nutrient interactions, helping readers make informed choices without relying on exaggerated health claims
